NCT05457465View on ClinicalTrials.gov

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

PHASE2RecruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Bipolar Disorder

Interventions

DRUG

Cannabidiol

Custom formulation of a hemp-derived, high-CBD product that contains no THC.

Trial Locations (1)

02478

RECRUITING

McLean Hospital, Belmont

All Listed Sponsors

lead

Mclean Hospital

OTHER